CN1062761C - 多功能消痛液及其制作方法 - Google Patents
多功能消痛液及其制作方法 Download PDFInfo
- Publication number
- CN1062761C CN1062761C CN98100150A CN98100150A CN1062761C CN 1062761 C CN1062761 C CN 1062761C CN 98100150 A CN98100150 A CN 98100150A CN 98100150 A CN98100150 A CN 98100150A CN 1062761 C CN1062761 C CN 1062761C
- Authority
- CN
- China
- Prior art keywords
- percent
- radix
- eupolyphaga
- rhizoma corydalis
- myrrha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 22
- 239000007788 liquid Substances 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- 241001489978 Eupolyphaga Species 0.000 claims abstract description 15
- 239000004863 Frankincense Substances 0.000 claims abstract description 15
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 14
- 241001057584 Myrrha Species 0.000 claims abstract description 14
- 239000009286 sanguis draxonis Substances 0.000 claims abstract description 14
- 238000005303 weighing Methods 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000002244 precipitate Substances 0.000 claims abstract description 4
- 238000007654 immersion Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 210000003934 vacuole Anatomy 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 31
- 230000036407 pain Effects 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 208000014674 injury Diseases 0.000 abstract description 5
- 206010047601 Vitamin B1 deficiency Diseases 0.000 abstract description 4
- 208000002894 beriberi Diseases 0.000 abstract description 4
- 241000628997 Flos Species 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 238000002791 soaking Methods 0.000 abstract 2
- 241000758794 Asarum Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 244000167230 Lonicera japonica Species 0.000 abstract 1
- 235000017617 Lonicera japonica Nutrition 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000003860 storage Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000008961 swelling Effects 0.000 description 6
- 208000009084 Cold Injury Diseases 0.000 description 5
- 206010053615 Thermal burn Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 230000002595 cold damage Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 4
- UCZJPQIEFFTIEV-UHFFFAOYSA-N 5-methoxy-6-methyl-2-phenylchromen-7-one Chemical compound C=1C=C2C(OC)=C(C)C(=O)C=C2OC=1C1=CC=CC=C1 UCZJPQIEFFTIEV-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 229930183118 Tanshinone Natural products 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- FWKBXSPDFCAHFN-UHFFFAOYSA-N Dracorubin Natural products C1CC=2C(OC)=CC=3OC(C=45)=C(C)C(=O)C=C5OC(C=5C=CC=CC=5)=CC=4C=3C=2OC1C1=CC=CC=C1 FWKBXSPDFCAHFN-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- -1 demethyl dracorubin Chemical compound 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N 1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid Chemical compound C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000009019 Pericoronitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229930190783 danshenxinkun Natural products 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- FWKBXSPDFCAHFN-DEOSSOPVSA-N dracorubin Chemical compound C1([C@H]2OC=3C=4C=5C=C(OC6=CC(=O)C(C)=C(C=56)OC=4C=C(C=3CC2)OC)C=2C=CC=CC=2)=CC=CC=C1 FWKBXSPDFCAHFN-DEOSSOPVSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 208000002557 hidradenitis Diseases 0.000 description 1
- 201000007162 hidradenitis suppurativa Diseases 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229930195208 isotanshinone Natural products 0.000 description 1
- 239000009416 jing wan hong Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000010672 sassafras oil Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- ZPCCSZFPOXBNDL-RSMXASMKSA-N spiramycin II Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]([C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)OC(C)=O)[C@H]1CC[C@H](N(C)C)[C@H](C)O1 ZPCCSZFPOXBNDL-RSMXASMKSA-N 0.000 description 1
- 229950006796 spiramycin ii Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种多功能消痛液及其制作方法，属于中药制剂。其各组分及重量百分比为紫草4-6、忍冬2.8-4.1、公英4-6、元胡2.8-4.1、丹参2.8-4.1、细辛0.8-1.4、土元1-2.5、血竭0.5-1、乳香1-2.5、没药1-2.5、75%医用乙醇68-73。其制作方法为将紫草、忍冬、公英、元胡、丹参、细辛、土元按重量百分比称取混合，放入烤箱中，烘烤，粉碎，放入规定量的75%医用乙醇中浸泡两周，再按重量百分比称取血竭、乳香和没药研细，加入到上述浸泡液泡一周，去掉沉淀物，取澄清液装瓶。本发明可治损伤、肿痛、脚气等多种疾病，见效快，疗程短，易制作保存，经济实用。
Description
本发明涉及一种多功能消痛液及其制作方法，属于治疗跌打损伤、风湿肿痛等疾病的中药制剂。
目前治疗跌打损伤、风湿肿痛、毒虫叮咬、疗胞肿毒、烧伤、冻伤、烫伤、乳腺炎、淋巴炎、肠胃酸痛、疮疹、湿疹、脚气等疾病的药物很多，如正红花油、伤湿止痛膏、好的快、冻伤膏、京万红软膏及治疗脚气的药物等，多为功能单一，疗效不明显，疗程长，有的还有过敏和继发性感染等。若患者同时患有几种疾病，则要同时用多种药物，不方便，费用高，且有些药物同时使用还会有副作用。
本发明的目的在于克服现技术中的不足，提供一种功能多，使用方便经济的多功能消痛液。
本发明的目的是这样实现的：它是紫草、忍冬、公英、元胡、丹参、细辛、土元、血竭、乳香、没药、75％医用乙醇浸液，其各组分及重量百分比为紫草4-6、忍冬2.8-4.1、公英4-6、元胡2.8-4.1、丹参2.8-4.1、细辛0.8-1.4、土元1-2.5、血竭0.5-1、乳香1-2.5、没药1-2.5、75％医用乙醇68-73。其制作方法为将紫草、忍冬、公英、元胡、丹参、细辛、土元按重量百分比称取混合，放入烤箱中，烘烤，粉碎，放入规定量的75％医用乙醇中浸泡两周，再按重量百分比称取血竭、乳香和没药研细，加入到上述浸泡液泡一周，去掉沉淀物，取澄清液装瓶。
与现有技术相比，本发明优点在于：
1、制作简单，使用方便，患处涂擦即可，经济实用。
2、疗效快，3-5分钟即可效，5-15分钟肿痛明显消退，疗程短，对一些疾病用药数次或数日即愈；
3、不产生过敏，无毒副作用，安全可靠；
4、功能多，适应症广，一药多用，并可免除一些内服药品对血液、肝、胃、肾系统的不良影响。
5、易保存，不冻，不腐，不失效，不变质。
下面结合实施例详述本发明。
本发明是是紫草、忍冬、公英、元胡、丹参、细辛、土元、血竭、乳香、没药、75％医用乙醇浸液，它的各组分及重量百分比为紫草4-6、忍冬2.8-4.1、公英4-6、元胡2.8-4.1、丹参2.8-4.1、细辛0.8-1.4、土元1-2.5、血竭0.5-1、乳香1-2.5、没药1-2.5、75％医用乙醇68-73。
各组分的重量百分比为紫草5.36、忍冬3.57、公英5.36、元胡3.57、丹参3.57、细辛1.1、土元1.78、血竭0.71、乳香1.78、没药1.78、75％医用乙醇71.42。本发明的制作方法为将紫草、忍冬、公英、元胡、丹参、细辛、土元按重量百分比称取混合，放入烤箱中，烘烤，粉碎，放入规定量的75％医用乙醇中浸泡两周，再按重量百分比称取血竭、乳香和没药研细，加入到上述浸泡液泡一周，去掉沉淀物，取澄清液装瓶。
药理分析：
紫草，清热解毒、凉血活血止血，可收缩血管并抑制金黄色葡萄球菌和大肠杆菌；
忍冬，疏风活络，消肿定痛，现代微观分析内含木犀草素，绿原酸，绿原酸，黄酮类，芳樟醇，双花醇，松油醇，苯甲醇荡烯，丁香油酚等，有广谱抗菌作用。
公英，清热解毒利湿，含公英留醇胆硷等有广谱抗菌作用，丹参，活血化瘀凉血有肿，含丹参酮，异丹参酮稳丹参酮，丹参素原儿茶醛、合留醇羟茎丹参酮丹参酸甲酯、丹参新醌等，并对结构杆菌，霍乱弧菌，和某些制病真菌有抑制作用，血竭，祛瘀见痛，止血，生肌疮，含血竭红素，血竭素，去甲基血竭红素，去甲基血竭素去氢松香酸，异松脂酸等，对堇色毛藓菌，石膏样毛癣菌，许兰氏毛癣菌等多种致病其菌有抑制作用，细辛，祛风解表，散寒止痛，含甲其丁香油酚黄樟油石迷，左旋细辛素有解热镇痛镇静抗炎作用。
元胡：活血祛瘀，消肿镇痛，含元胡甲素、乙素、戊素、己素、庚素、寅素、丑素等多种生物硷。
土元：破血逐瘀，续盘接骨。
乳香没药：含挥发油、树脂、树胶、活血止痛消肿生肌。
本发明具有较强的活血化瘀、消肿止痛，杀菌解毒、去腐生肌、止血止痒等功效，主要用于跌打损伤、风湿肿痛、疔疮肿毒、毒虫叮咬、烧伤、烫伤、冻伤、牙周肿痛、非急性化脓性、浆液性牙骨水炎所制的牙痛、面部毛囊炎粉刺感染、口唇泡疹、乳腺炎、腮腺炎、湿疹瘙痒、糜烂型脚气病、经久不愈的软组织溃、关节屈伸不利手足关节肿痛肌纤维炎、浅淋巴结炎、胃肠绞痛、痱毒咽喉肿痛。
使用本发明，可在病处涂擦每日3-5次，涂药1分钟即有明显的轻快感，2-3分钟肿胀疼痛明显消退，药效可持续10-20小时以上。
本发明以丰润县人民医院临床试验418例，有效397例，占95％，治愈355例，占85％。
实施例：
以生产100kg为例，各组份的配比重量(kg)如下表：
| 紫草 | 忍冬 | 公英 | 元胡 | 丹参 | 细辛 | 土元 | 血竭 | 乳香 | 没药 | 乙醇 | |
| 1 | 4.5 | 3.8 | 4.5 | 3.9 | 3 | 1 | 2.2 | 0.6 | 2.2 | 1.3 | 73 |
| 2 | 4.5 | 3.5 | 5 | 3.5 | 3.5 | 1.2 | 2.4 | 0.65 | 1.8 | 1.9 | 72.0 |
| 3 | 5.36 | 3.57 | 5.36 | 3.57 | 3.57 | 1.1 | 1.78 | 0.71 | 1.78 | 1.78 | 71.4 |
| 4 | 5 | 3.5 | 5.8 | 3.8 | 4 | 0.9 | 1.8 | 0.9 | 2.4 | 1.6 | 70 |
各实施例的制作方法为上所述。
典型病例：
1、何某、女、25岁，丰润县工商局职工，96年12月患左侧乳腺炎，住中医院输入抗菌素5天效不佳，因其父患手冻伤肿痛痒，上药15分钟后见奇效，痛痒消失，红肿消退，当晚8点钟带药到中医院病房为其女涂药一次，次日早见肿痛明显消退，其父母非常高兴，当日办理出院手续，回家上药两天结告愈。
2、常某某，14岁，丰润县常庄村人，双手双脚冻伤溃烂月余，涂冻疮膏等药无效，上药5次伤口结愈痂愈合告愈。
3、阴某某，男，34岁，丰润县七树庄村人，左脚踝关节挫伤月余，助拐跛行，曾用其它跌打损伤药效不佳，不能劳做，96年3月上药50毫升后，药尽病愈重反建筑队上班，因药效神奇，来院告愈时又带药50毫升家中备用。
4、李某某，男，53岁，丰润县小屯村人因牙齿肿痛来院就诊，查，冠周炎叩P(+)有自发痛，咬合痛，上药5分钟后痛止，带药回家，巧有本村轧钢厂工人烫伤，上药后5分钟痛止，数日即愈，该村有钢厂百余家，带有不慎烫伤者，以往均用市售烧烫伤药物，但均不如“多功能消痛液”，故被村医务室定为常备药品。
5、于某，女，13岁，丰润县小学生，患脐周腹痛，曾用解痉止痛药及蛔虫药，96年12月22日发病，时当即脐部涂药20×20厘米，3分钟后痛消。
6、张某某，女，53岁，丰润县二化工人，96年10月份因患咽炎后，右上颈浅淋巴结肿，查表皮，弥散性肿大，皮色正常，触痛，过界清，2×2厘米大小，当即上药两次，20分钟后症减见消，带药回家自用一次，病消告愈，次日来院报喜，因原来曾服用中药三剂，打消炎针三针，乙酰螺旋霉素三板而不见效，药费120多元，仅上多功能消痛液3次病愈，故带药50毫升为家中备用。
Claims (3)
1、一种多功能消痛液，其特征在于它是紫草、忍冬、公英、元胡、丹参、细辛、土元、血竭、乳香、没药、75％医用乙醇浸液，它的各组分及重量百分比为紫草4-6、忍冬2.8-4.1、公英4-6、元胡2.8-4.1、丹参2.8-4.1、细辛0.8-1.4、土元1-2.5、血竭0.5-1、乳香1-2.5、没药1-2.5、75％医用乙醇68-73。
2、根据权利要求1所述的一种多功能消痛液，其特征在于各组分及重量百分比为紫草5.36、忍冬3.57、公英5.36、元胡3.57、丹参3.57、细辛1.1、土元1.78、血竭0.71、乳香1.78、没药1.78、75％医用乙醇71.42。
3、权利要求1的一种多功能消痛液的制作方法，其特在于将紫草、忍冬、公英、元胡、丹参、细辛、土元按重量百分比称取混合，放入烤箱中，烘烤，粉碎，放入规定量的75％医用乙醇中浸泡两周，再按重量百分比称取血竭、乳香和没药研细，加入到上述浸泡液泡一周，去掉沉淀物，取澄清液装瓶。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98100150A CN1062761C (zh) | 1998-01-22 | 1998-01-22 | 多功能消痛液及其制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98100150A CN1062761C (zh) | 1998-01-22 | 1998-01-22 | 多功能消痛液及其制作方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1223869A CN1223869A (zh) | 1999-07-28 |
| CN1062761C true CN1062761C (zh) | 2001-03-07 |
Family
ID=5215837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98100150A Expired - Fee Related CN1062761C (zh) | 1998-01-22 | 1998-01-22 | 多功能消痛液及其制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1062761C (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393872A (zh) * | 2013-08-05 | 2013-11-20 | 王振卿 | 抗风湿膏及制备方法 |
| CN103479980B (zh) * | 2013-09-22 | 2015-04-22 | 王贵胜 | 一种治疗急性淋巴结炎的膏药 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1031186A (zh) * | 1988-03-29 | 1989-02-22 | 吴大勇 | 特效骨刺消炎膏的配方及制作法 |
| CN1127129A (zh) * | 1995-01-16 | 1996-07-24 | 徐永林 | 治疗烧烫伤的外敷药及其制作方法 |
-
1998
- 1998-01-22 CN CN98100150A patent/CN1062761C/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1031186A (zh) * | 1988-03-29 | 1989-02-22 | 吴大勇 | 特效骨刺消炎膏的配方及制作法 |
| CN1127129A (zh) * | 1995-01-16 | 1996-07-24 | 徐永林 | 治疗烧烫伤的外敷药及其制作方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1223869A (zh) | 1999-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105833279B (zh) | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 | |
| CN104688810A (zh) | 一种基于天然植物原料的抗菌组合物及其应用 | |
| CN103110868B (zh) | 一种皮肤护理液及其制备方法 | |
| CN103393902B (zh) | 一种检验科外伤杀菌消炎药物及制备方法 | |
| CN103041111B (zh) | 一种妇科会阴护理液及其制备方法 | |
| CN103230493B (zh) | 一种治疗创口不愈的中药组合物 | |
| CN105343332B (zh) | 茵陈虎杖复方药膏剂及其制备方法 | |
| CN102727640B (zh) | 一种用于治疗甲沟炎的外用药膏 | |
| CN113332350A (zh) | 一种复方本草抑菌液及其制备工艺、应用 | |
| CN101455748B (zh) | 一种消炎生肌药及其制备方法 | |
| CN1062761C (zh) | 多功能消痛液及其制作方法 | |
| CN107007761B (zh) | 一种中药烧伤油及其制备方法 | |
| CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
| CN109731040A (zh) | 一种外伤修复组合物、制备方法及其应用 | |
| CN102106920B (zh) | 一种治疗烧烫伤的中药组合物及其用途 | |
| CN101690760B (zh) | 一种治疗创伤的药物组合物及其药膏制备方法、应用 | |
| CN1864729A (zh) | 一种纯中药外伤消敛药物 | |
| CN102743587A (zh) | 一种外用创伤修复液 | |
| CN104922614A (zh) | 一种中药褥疮膏 | |
| CN106728069B (zh) | 一种治疗烫烧伤的祛腐生肌膏 | |
| CN107050298A (zh) | 一种治疗烧烫伤皮损的中药膏配方及制备方法 | |
| RU2782695C1 (ru) | Состав для наружного применения "септисол" | |
| CN101559185A (zh) | 一种治疗下肢静脉曲张的外用药物 | |
| CN1269511C (zh) | 一种护肤中药 | |
| CN105168448A (zh) | 一种复方烧伤膏及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |